The death of biology

At Harvard, biology is an endangered species. Next fall's wide-eyed freshmen will have to head down the street to Massachusetts Institute of Technology if they want to concentrate (Harvard-speak for major) in the subject, because it will no longer be offered in Harvard Square. This change was puzzling to my editor, who concentrated in biology at Harvard, and to me, a 2005 graduate with a degree in biochemistry. So I consulted Robert Lue, my former advisor and cochair

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

At Harvard, biology is an endangered species. Next fall's wide-eyed freshmen will have to head down the street to Massachusetts Institute of Technology if they want to concentrate (Harvard-speak for major) in the subject, because it will no longer be offered in Harvard Square.

This change was puzzling to my editor, who concentrated in biology at Harvard, and to me, a 2005 graduate with a degree in biochemistry. So I consulted Robert Lue, my former advisor and cochair of the Life Sciences Education Committee. "One of the problems with biology was it was too broad, too amorphous," says Lue, a senior lecturer on molecular and cellular biology. "I mean, what is biology?"

Harvard professor Douglas Melton, perhaps best known for his advocacy of embryonic stem cell research, assembled the committee two summers ago in an attempt to answer that question. Over the course of almost weekly meetings lasting two to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ishani Ganguli

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo